LMR Partners’s Northwest Biotherapeutics NWBO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
– Sell
-102,686
Closed -$60K – 613
2016
Q2
$60K Buy
+102,686
New +$110K 0.01% 431
2015
Q2
– Sell
-16,177
Closed -$119K – 660
2015
Q1
$119K Buy
+16,177
New +$109K 0.02% 370

Other funds holding NWBO

LMR Partners's NWBO Position: Q3 2016 in Review

LMR Partners sold out of Northwest Biotherapeutics (NWBO) in Q3 2016, closing a stake of 102,686 shares — an estimated $60K sold.

LMR Partners first reported a position in NWBO in Q1 2015 and held it in 2 quarters. The position peaked at $119K in Q1 2015. 54 funds tracked by Wall St. Rank hold NWBO as of Q3 2016.

  • LMR Partners reported no remaining Northwest Biotherapeutics position as of Q3 2016 after selling out during the quarter.
  • LMR Partners sold 102,686 Northwest Biotherapeutics shares in Q3 2016, an estimated $60K.
  • LMR Partners first reported a position in Northwest Biotherapeutics in Q1 2015 and held it in 2 quarters.
  • LMR Partners's Northwest Biotherapeutics position peaked at $119K in Q1 2015.
  • 54 funds tracked by Wall St. Rank held Northwest Biotherapeutics as of Q3 2016.

Based on LMR Partners's 13F filing for Q3 2016, filed 1 Nov 2016.